Skip to main content
. 2020 Feb 15;12(2):156. doi: 10.3390/pharmaceutics12020156

Table 3.

List of the investigated usnic acid-loaded polymeric nano- and microcarriers.

Potential Therapy Composition Particle Size EE (%) Stability Purpose Ref.
Polymeric Nanoparticles
Nanocapsules
Sarcoma PLGA, soybean oil, PC, poloxamer F68 324 ± 88 nm 99.4 ± 0.2 36 months Enhancement of antitumor activity and reduction of hepatotoxicity [31,32]
Nanospheres
Lung cancer Heparin–ADH–GG copolymer, Pluronic F 68 83.38 ± 1.18nm 99.98 ± 0.50 n.a. Site-specific delivery in the cancer cells [33]
Polymeric Nanofibers
Diabetic wound healing treatment Eudragit L100 or PVP n.a. n.a. n.a. Improvement of antimicrobial activity against S. aureus [34]
Polymeric Microparticles
Sarcoma PLGA, PEG, PVA, Poloxamer F68 7.02 ± 2.74 μm ∼100 7 months Enhancement of antitumor activity and reduction of hepatotoxicity [35]
Inflammation PCL, PEG, PVA 13.54 μm 97.72 n.a. Enhancement of anti-inflammatory activity and reduction of acute toxicity [36]
Infected chronic wounds CPLLA 2.4 ± 0.8 μm 80 n.a. Improvement of antibiofilm activity against S. epidermidis [37]
Wounds and burns, implanted device-related infections * PLA, PVA, Ti 5 µm n.a. n.a. Improvement of antibiofilm activity against S. aureus [38]
Wounds and burns, implanted device-related infections ** PLGA, PVA, Fe3O4, myristic acid, Ti 5–20 µm n.a. n.a. Improvement of antibiofilm activity against S. aureus [39]

EE: entrapment efficiency; PLGA: Poly (d,l-lactic-acid-co-glycolic acid) polymer; PC: soybean phosphatidylcholine; ADH: adipic acid dihydrazide; GG: gellan gum; n.a.: not applicable; PVP: polyvinylpyrrolidone; PEG: poly ethylene glycol; PVA: polyvinyl alcohol; PCL: poly-𝜀-caprolactone; CPLLA: carboxylated poly(l-lactide); Ti: Titanium;* thin film based on PLA-PVA microspheres deposited to Ti substrates.** thin film based on PLGA-PVA microspheres containing Fe3O4 nanoparticles coated with myristic acid deposited to Ti substrates.